Program By Day

7:00 AM-8:00 AM Complimentary Continental Breakfast
7:00 AM-6:30 PM Exhibits Open
7:50 AM-9:30 AM Welcome and General Session 1: Response Assessment and Individualization of Management of Esophageal Adenocarcinoma (ARS)

Sarah E. Hoffe, MD - Chair
Moffitt Cancer Center

Gail Elizabeth Darling, MD - Chair
Toronto General Hospital, University Health Network

Laura A. Dawson, MD
Princess Margaret Cancer Centre
Welcome of the Day

Case Presentation

Kenneth Wang, MD
Mayo Clinic
Initial Staging and Response Assessment

Debate: Management of Esophageal Adenocarcinoma After Neoadjuvant Therapy With Complete Clinical Response—Surgery Versus Watchful Waiting

TBD
Surgeon Perspective

Florence Huguet, MD, PhD
Hopital Tenon
Radiation Oncologist Perspective

David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center
Improving Esophageal Adenocarcinoma Outcomes: Future Directions

Panel Question and Answer
9:30 AM-10:00 AM Break
10:00 AM-11:30 AM General Session 2: Global Outlook on Gastric Cancer

Ulysses Ribeiro Jr., MD, PhD - Chair
University of Sao Paulo

Khaldoun Almhanna, MD, MPH - Chair
Moffitt Cancer Center

Global Perspectives on Surveillance, Risk Factors, and Management of Early Gastric Cancer

Alexander G. Meining
Medical School of the University of Ulm
European Perspective

Paola Catherine Montenegro, MD
Instituto Nacional De Enfermedades Neoplasicas
South American Perspective

Seiichiro Abe, MD
National Cancer Center, Tokyo
Asian Perspective

TBD
Foregut Microbiome: Advances in Our Understanding of Its Role in Gastric Cancer and Its Management

Hold for Potential Abstract

Panel Question and Answer
11:30 AM-1:00 PM Poster Session A: Cancers of the Esophagus and Stomach
11:30 AM-1:00 PM Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach
With Complimentary Boxed Lunch
12:00 PM-1:00 PM Trainee and Early-Career Networking Luncheon
1:00 PM-2:00 PM Rapid-Fire Abstract Session: Cancers of the Esophagus and Stomach
1:00 PM-2:00 PM Breakout Session: Multidisciplinary Management of Less Common Gastroesophageal Tumors

Ronald P. DeMatteo, MD
Perelman School of Medicine at the University of Pennsylvania
Guidelines for Perioperative Imatinib Therapy for Gastrointestinal Stromal Tumors

Field F. Willingham, MD, MPH
Emory University School of Medicine
Evaluation of Gastroesophageal Submucosal Lesions and Minimally Invasive Management Options

Panel Question and Answer
1:00 PM-2:00 PM Breakout Session: FLOT or Not—Perioperative Management for Gastric Cancer

Salah-Eddin Al-Batran, MD
Institute of Clinical Cancer Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center
Pro

Jaffer A. Ajani, MD
The University of Texas MD Anderson Cancer Center
Con

Panel Question and Answer
2:00 PM-2:15 PM Break
2:15 PM-3:45 PM Oral Abstract Session A: Cancers of the Esophagus and Stomach
3:45 PM-4:15 PM Break
4:15 PM-5:30 PM General Session 3: Is There a Role for Locoregional Therapies in Stage IV Esophageal and Gastric Cancers? (ARS)

Paola Catherine Montenegro, MD - Chair
Instituto Nacional De Enfermedades Neoplasicas

Manisha Palta, MD - Chair
Duke University Medical Center

Case Presentation and Discussion

Brian D. Badgwell, MD
The University of Texas MD Anderson Cancer Center
Surgical Oncologist Perspective

Elena Elimova, MD
Princess Margaret Cancer Centre
Medical Oncologist Perspective

Maria A Hawkins, FRCR, MD, MRCP
University of Oxford
Radiation Oncologist Perspective
5:30 PM-6:30 PM Poster Session A: Cancers of the Esophagus and Stomach
With Complimentary Wine and Cheese Reception
5:30 PM-6:30 PM Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach
5:45 PM-6:30 PM Poster Walks